Drug Testing

Endo International plc, the manufacturer of an extended release formulation of oxycodone known as Opana ER, announced July 6 that it was voluntarily complying with a request from the U.S. Food [...]

The use of plant materials to relieve suffering, treat illness or conduct religious ceremonies has a long history. Occasionally, the Industry News will look more closely at the history of a [...]

Widely heralded as the “antidote” to opioid overdoses, naloxone was first patented in New York in 1961 by scientists looking to treat constipation caused by chronic opioid use. Despite being [...]

Frustrated with the continually rising number of opioid overdoses, law enforcement officials across the country are taking a more active role in combating the opioid epidemic, one that does not [...]

In a recent article, The New York Times estimates that more than 59,000 people died of drug overdoses in 2016, an increase of 19 percent over drug deaths in 2015. If this estimate proves to be [...]

A Deadly Combination of Fentanyl, Carfentanil and Heroin Grey death, the latest in an ever-evolving landscape of dangerous street drugs, is being blamed for several fatal overdoses in Georgia. [...]

On Saturday, April 29, 2017, the Drug Enforcement Agency is holding its next prescription drug take-back day, its thirteenth such event in seven years. The goal of take-back programs is to [...]

New research funded by the Substance Abuse and Mental Health Services Administration (SAMHSA) has determined techniques to increase adoption of prescription drug monitoring programs (PDMPs), [...]

In response to the opioid epidemic, communities around the country are launching new awareness campaigns that depict the devastating impact of teenage overdoses from prescription painkillers. The [...]

This is the third article in a series about the complex issues around treatment for substance use disorders, particularly with regard to opioids. Abstinence is a centuries-old method for treating [...]